Advocacy at a Glance Guest User 9/11/20 Advocacy at a Glance Guest User 9/11/20 Following the Science to Protect Public Health Read More Advocacy at a Glance Guest User 9/11/20 Advocacy at a Glance Guest User 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More Analysis and Commentary Guest User 9/3/20 Analysis and Commentary Guest User 9/3/20 Understanding Tom Frieden's Proposed HDO Read More Advocacy at a Glance Guest User 9/4/20 Advocacy at a Glance Guest User 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More Analysis and Commentary Guest User 8/14/20 Analysis and Commentary Guest User 8/14/20 "Somehow the CR Will Pass", But When? Read More Advocacy at a Glance Guest User 8/14/20 Advocacy at a Glance Guest User 8/14/20 Party Platforms Don’t Matter, Probably Read More Analysis and Commentary Guest User 8/7/20 Analysis and Commentary Guest User 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More Advocacy at a Glance Guest User 8/7/20 Advocacy at a Glance Guest User 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Analysis and Commentary Guest User 8/1/20 Analysis and Commentary Guest User 8/1/20 About the Alliance for a Stronger FDA Read More Advocacy at a Glance Guest User 8/1/20 Advocacy at a Glance Guest User 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More Advocacy at a Glance Guest User 7/26/20 Advocacy at a Glance Guest User 7/26/20 FY 21 Appropriation: Qs&As Read More Advocacy at a Glance Guest User 7/26/20 Advocacy at a Glance Guest User 7/26/20 House Appropriations Minibus Containing FY 21 Ag/FDA Funding Advances Read More Analysis and Commentary Guest User 7/18/20 Analysis and Commentary Guest User 7/18/20 Why No Movement in the Senate? Read More Advocacy at a Glance Guest User 7/18/20 Advocacy at a Glance Guest User 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More Analysis and Commentary Guest User 7/10/20 Analysis and Commentary Guest User 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance Guest User 7/10/20 Advocacy at a Glance Guest User 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More Analysis and Commentary Guest User 6/26/20 Analysis and Commentary Guest User 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance Guest User 6/26/20 Advocacy at a Glance Guest User 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Analysis and Commentary Guest User 6/19/20 Analysis and Commentary Guest User 6/19/20 How Well Is This Year's Appropriation Process Working? Read More Advocacy at a Glance Guest User 6/19/20 Advocacy at a Glance Guest User 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Newer Posts Older Posts
Advocacy at a Glance Guest User 9/11/20 Advocacy at a Glance Guest User 9/11/20 Following the Science to Protect Public Health Read More
Advocacy at a Glance Guest User 9/11/20 Advocacy at a Glance Guest User 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More
Analysis and Commentary Guest User 9/3/20 Analysis and Commentary Guest User 9/3/20 Understanding Tom Frieden's Proposed HDO Read More
Advocacy at a Glance Guest User 9/4/20 Advocacy at a Glance Guest User 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More
Analysis and Commentary Guest User 8/14/20 Analysis and Commentary Guest User 8/14/20 "Somehow the CR Will Pass", But When? Read More
Advocacy at a Glance Guest User 8/14/20 Advocacy at a Glance Guest User 8/14/20 Party Platforms Don’t Matter, Probably Read More
Analysis and Commentary Guest User 8/7/20 Analysis and Commentary Guest User 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More
Advocacy at a Glance Guest User 8/7/20 Advocacy at a Glance Guest User 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Analysis and Commentary Guest User 8/1/20 Analysis and Commentary Guest User 8/1/20 About the Alliance for a Stronger FDA Read More
Advocacy at a Glance Guest User 8/1/20 Advocacy at a Glance Guest User 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More
Advocacy at a Glance Guest User 7/26/20 Advocacy at a Glance Guest User 7/26/20 FY 21 Appropriation: Qs&As Read More
Advocacy at a Glance Guest User 7/26/20 Advocacy at a Glance Guest User 7/26/20 House Appropriations Minibus Containing FY 21 Ag/FDA Funding Advances Read More
Analysis and Commentary Guest User 7/18/20 Analysis and Commentary Guest User 7/18/20 Why No Movement in the Senate? Read More
Advocacy at a Glance Guest User 7/18/20 Advocacy at a Glance Guest User 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More
Analysis and Commentary Guest User 7/10/20 Analysis and Commentary Guest User 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Advocacy at a Glance Guest User 7/10/20 Advocacy at a Glance Guest User 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More
Analysis and Commentary Guest User 6/26/20 Analysis and Commentary Guest User 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Advocacy at a Glance Guest User 6/26/20 Advocacy at a Glance Guest User 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Analysis and Commentary Guest User 6/19/20 Analysis and Commentary Guest User 6/19/20 How Well Is This Year's Appropriation Process Working? Read More
Advocacy at a Glance Guest User 6/19/20 Advocacy at a Glance Guest User 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
